Insulet (PODD) Sales Momentum Appears Sustainable - Leerink; PT to $50
Leerink Partners analyst Danielle Antalffy reiterated an Outperform rating but trimmed her price target on Insulet Corporation (NASDAQ: PODD) to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)